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ABSTRACT
Tail-anchored (TA) membrane proteins are critical for protein translocation, intracellular trafficking, and 
programmed cell death. TA proteins contain hydrophobic transmembrane domains and traverse through the cytosol 
to post-translationally insert into cellular membranes.  It is unclear how this post-translational insertion is affected by 
Endoplasmic Reticulum (ER) stress.  Here, we find that TA protein insertion is significantly reduced with ER stress 
inducer thapsigargin (Tg), a calcium pump inhibitor that blocks the import of calcium into the ER causing ER stress, 
but not when treated with other ER stress inducers. Interestingly, out data suggests that increased calcium in the 
cytosol may decrease TA protein insertion rather than ER stress.  One potential mechanism for this is the calcium-
dependent activation of chaperone, calmodulin, which acts like a trap for TA proteins under certain physiological 
conditions. 
Tail-Anchored Protein Insertion Under ER 
Stress Conditions: Calcium is Key
By Matthew Jordan1, Malaiyalam Mariappan2
1Department of Molecular, Cellular, and Developmental Biology, Yale University
2Department of Cell Biology, Yale School of Medicine
INTRODUCTION
Membrane proteins account for approximately 35% of the cellu-
lar proteome and are essential for a variety of cellular activities 
including cell-cell signaling, transport of nutrients and waste prod-
ucts across cells, capture of energy and transduction into usable 
form, and communication with the environment1.  A shared feature 
of membrane proteins is the highly hydrophobic transmembrane 
domain (TMD), which anchors the protein inside the lipid bilayer. 
Thus, a fundamental challenge in membrane protein insertion is 
the movement of these hydrophobic TMDs from the aqueous cy-
tosol, where they are synthesized, to the lipid bilayer, where they 
are energetically most stable2.  The process requires selective TMD 
recognition, shielding of the hydrophobic TMD from the aqueous 
cytosol, targeting to the correct membrane surface, and integration 
of the TMD into the lipid bilayer in the correct orientation3.  The 
solution couples protein synthesis and insertion at the ER, termed 
the co-translational protein insertion pathway4.  The TMD of the 
membrane protein is co-translationally recognized and bound by the 
signal recognition particle (SRP) in the cytosol5.  The SRP-bound 
ribosome nascent chain complex is then delivered to the ER-local-
ized SRP receptor.  The nascent chain is co-translationally integrat-
ed into the ER membrane via the Sec61 translocon pore6. Fidelity 
is maximized as protein synthesis and insertion of the hydrophobic 
TMD are coupled at the ER membrane, thereby minimizing expo-
sure and aggregation of the TMD in the cytosol (Fig. 1a).
Tail-anchored (TA) membrane proteins are a special class of mem-
brane proteins that are critical for protein translocation, intracellular 
trafficking, and programmed cell death. TA proteins are highlighted 
by a TMD on the C-terminus that dictates its membrane orientation 
and an N-terminal domain that provides functionality and faces the 
cytoplasm.  Due to the topology of TA proteins—TMD on C-termi-
nus—these membrane proteins are precluded from SRP binding7. 
Protein synthesis occurs in the N-C direction.  Since TA proteins 
contain a TMD on the C-terminus, SRP is unable to bind and pause 
translation because translation is terminated prior to the full emer-
gence of the TMD from the ribosomal exit tunnel.
Targeting and insertion occur after complete synthesis of the mem-
brane protein substrate.  Additional factors shield the hydrophobic 
TMD of the TA protein and deliver it to the correct membrane.  The 
basic paradigm of post-translational membrane insertion consists 
of cytosolic chaperones which mediate recognition, shielding and 
transport. These chaperones interact with a specific ER-localized 
receptor that dictates targeting and insertion.  Genetic and biochem-
ical research have identified cytosolic and membrane factors in-
volved in this post-translational (GET/TRC) pathway11.  The GET/
TRC pathway in yeast/mammals routes TA proteins, especially 
those with higher hydrophobicity, to the ER for insertion12 (Fig. 1b).
Despite significant progress in elucidating the mechanism of TA 
protein trafficking, delivery, and insertion, it remains unclear how 
TA proteins are regulated under stress conditionsi.  We believe that 
stress conditions affects TA protein synthesis since ER stress elicits 
a set of cellular responses which increases the ER machinery’s ca-
pacity to fold and degrade proteins, while upregulating the produc-
tion of chaperones that prevent protein misfolding in the cytosol17. 
Here, we find that TA protein insertion is significantly reduced with 
ER stress inducer thapsigargin (Tg) but not with other ER stress 
inducers.
1YURJ | Vol 2.1Spring 2021
Jordan | Cell Biology
i ER stress occurs when the capacity of the ER to fold becomes saturated, or when 
demand for protein folding cannot be met by the capacity of ER to fold proteins. 
A number of physiological and pathological conditions are able to perturb prop-
er ER function and induce ER stress.  Triggers for ER stress include intracellular 
alterations (calcium or redox imbalances), certain microenvironmental conditions 
(hypoxia, acidosis, hypoglycemia), natural compounds (thapsigargin, tunicamycin, 
dithioltrithol), or overexpression of or mutations in proteins that prevent proper 
folding.9  
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Figure 1a. Schematic diagrams of co- and post-translational 
protein insertion mechanisms.
 
Figure 1b. The additional factors needed to shield TA proteins 
shown in second image (GET/TRC pathway)12:
1. After the nascent TA peptide chain is synthesized 
and released from ribosome, it is captured by Sgt2 
with the aid of Hsp70.
2. Sgt2 loaded with TA-protein binds to pre-targeting 
complex and transfers client to Get3, which is in its 
closed, ATP-bound form (tense state)
3. Cargo-loaded Get3 dissociates from pre-targeting 
complex
4. Cargo-loaded Get3 is captured—most likely after 
ATP hydrolysis—by Get2 at the ER membrane
5. Interaction of carbo-loaded Get3 with Get1 drives 
transition of Get3 to open state with the release of 
ADP (relaxed state) and insertion of TA TMD into 
bilayer
6. ATP binding and interaction with Get4/Get5 
drive dissociation of Get3 from ER receptor 
and its recruitment to another cycle of substrate 
engagement12
Figure 1 drawn by Jacob Culver
Figure 2. (A + B) FLAG-tagged βVamp2 was transfected into 
Hek293 cells and subject to ER-stress inducers: Tg (1 ug/mL) and 
DTT (4 mM).  The percentage of hlycosylation (Gly) is a proxy for 
successful TA protein insertion into the ER, which is calculated 
by glycosylated protein/(glycosylated protein + non-glycosylated 
protein)*100.  Intensity of bands were quantified in ImageJ
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RESULTS
The first question we wanted to address was how would TA protein 
insertion be affected under stress conditions?  We hypothesized that 
it was not stress conditions, but rather changes in intracellular calci-
um that affected the TA protein insertion rate.  To test this hypoth-
esis, we compared ER stress inducer, Thapsigargin—a non-com-
petitive inhibitor of the sarco/endoplasmic reticulum Ca2+ ATPase 
pump that increases cytosolic calcium concentration—to the ER 
stress inducer dithioltrithol (DTT) that do not affect calcium lev-
els but interferes with the disulfide bond formation of proteins in 
the ER.  First, we co-transfected HEK293 cells with FLAG-tagged 
Vamp2, an abundant TA protein involved in the targeting and fusion 
of transport vesicles to their target membranes.  We then treated 
cells with ER stress inducers, Tg and DTT, across different time 
points (Figure 2).  Following this treatment, we starved the cells 
with medium lacking methionine/cysteine (M/C), radiolabeled with 
35S methionine, and harvested in RIPA buffer.  The cell lysates 
were immunoprecipitated for βVamp2 using anti-FLAG beads. The 
immunoprecipitated samples were separated on a SDS-PAGE gel 
and process for autoradiography.  Since we appended a C-termi-
nal glycosylation tag to the C-terminus of βVamp2, the insertion 
into the ER can be monitored by its glycosylation from ER-local-
ized N-glycosylation machinery (Gly %). The result showed that 
βVamp2 glycosylation for Tg treated samples at all timepoints de-
creased in comparison to the control (no stress treatment), whereas 
the glycosylation for DTT samples were similar to controls (Figure 
2A, B).  Taken together, these results indicate that TA protein inser-
tion, represented by the glycosylation band, was reduced following 
Tg treatment, but not DTT treatment. 
We next asked whether the reduced TA protein insertion was depen-
dent on Tg concentration. We hypothesized that TA protein inser-
tion would decrease proportionally as Tg concentration increased. 
Our results show that the reduced TA protein insertion—decreased 
glycosylation-to-total protein ratio compared to the control—oc-
curred across all Tg concentrations (Figure 3).  However, we do 
not observe a proportional decrease in TA protein insertion with 
increasing Tg concentration.  We will need to rerun this experiment 
to confirm the relationship of Tg concentration to TA protein inser-
tion using a larger range of Tg concentrations.
We next hypothesized that the decreased protein insertion observed 
in βVamp2 upon introduction of Tg should hold across a range of 
TA protein constructs.  We performed the same experiment using 
ER-targeted TA protein constructs of varying hydrophobicityii 
(Otoferlin, βVamp2, VAPA, Sec61B, Cb5, Bcl2) treated with Tg 
(1 ug/mL) for 1 hour.  Control samples were not treated with Tg. 
We observed clear reduction in TA protein insertion in βVamp2 and 
Bcl2 along with minor reduction in Otoferlin and VAPA (Figure 4). 
This evidence supports our hypothesis that Tg-induced reduction 
in TA protein insertion occurs in a variety of TA protein constructs 
and is indicative of an underlying mechanism.  However, it remains 
unclear why protein insertion is not reduced in all TA protein con-
structs.
In a final set of experiments, we investigated the underlying mech-
anisms behind Tg-induced reduction in TA protein insertion.  We 
hypothesized that the key to decreased TA protein insertion was 
calcium.  Thapsigargin is a noncompetitive inhibitor of sarco/en-
doplasmic reticulum Ca2+ ATPase that blocks calcium flow into 
the ER and raises the cytosolic calcium.  It has been shown that 
increases in Ca2+ concentration occur during cell death conditions 
and ER stress, with calcium acting as a key signaling molecule to 
trigger apoptosis14.  We hypothesized that one of these calcium-in-
duced mechanisms to stimulate apoptosis or reduce ER stress is 
to reduce TA protein insertion—TA proteins such as Bcl2 are key 
anti-apoptotic factors and decreasing the rate of protein insertion 
helps relieve ER stress.  One potential mechanism for this to oc-
cur is for calcium to activate abundant, Ca2+-dependent chaperone, 
calmodulin, which acts like a trap for TA proteins under certain 
physiological conditions13.  To test this hypothesis, we performed 
chemical crosslinking experiment between βVamp2 and calmod-
ulin.  
We co-transfected HEK293 cells with FLAG-tagged βVamp2 and 
induced protein expression with 100 ng/mL of doxycycline.  We 
then treated cells with 1 ug/mL Tg for 1 hour.  Following treatment, 
we starved the cells with medium lacking M/C, radiolabelled with 
35S methionine, and added 0uM, 200 uM, and 500 uM of DSS cross 
linker into 1 mL KHM buffer.  After 30 min incubation at room 
temperature, we quenched the reaction by adding 0.1 M Tris pH 
8.0.  The cell lysates were immunoprecipitated for βVamp2 using 
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ii When referencing the “hydrophobicity of TA proteins” I am referring to the hydro-
phobicity of the TA proteins’ TMD which can be calculated through online protein 
sequencing databases16.  Hydrophobicity was chosen as a variable to test different 
TA protein constructs since TMD hydrophobicity is an important factor that deter-
mines targeting and function.1
Figure 3. FLAG-tagged βVamp2 was subject to ER-stress inducer, Tg (1 
ug/mL), for 1 hour at different concentrations (0 ug/mL->5 ug/mL). 
Figure 4. TA protein constructs (Otoferlin, βVamp2, VAPA, Sec61B, Cb5, 
Bcl2) were transfected into HEK293 cells and treated with TG (1 ug/mL) 
for 1 hour. Constructs arranged left-to-right in the order of decreasing 
TMD hydrophobicity.  
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anti-FLAG beads.  Each DSS cross linker concentration had a non-
TG treated control.  If our cross-linking experiment was successful, 
and our hypothesis is correct—calmodulin interacts with and inhib-
its TA proteins from being inserted into the ER—we expect to see 
a 32 kD band from immunoblotting analysis (both calmodulin and 
βVamp2 are roughly 16 kD) for the 200 and 500 uM DSS samples. 
Our result showed minimal cross-linking around the 32 kD band 
in the DSS treated samples (Figure 5).  From our data, we cannot 
definitely determine the mechanism behind the TG-induced reduc-
tion in TA protein insertion.  We will perform more experiments to 
optimize the DSS cross linker or via an alternative crosslinker to 
determine whether the Ca2+ activated calmodulin-trap is the mech-
anism by which TA protein insertion is reduced under Tg-induced 
conditions. 
DISCUSSION
Despite a better understanding of the mechanisms undergirding 
TA protein trafficking, delivery, and insertion, our understanding 
of how TA proteins—such as Bcl2 that provide crucial anti-apop-
totic activity9—are regulated under stress physiological conditions 
remains limited.  This paper shows that TA protein insertion is re-
duced with ER stress inducer thapsigargin (TG) but not with other 
ER stress inducers.
Our data suggests increased calcium in the cytosol is the key.  In-
creased intracellular calcium may act as a signal to inhibit TA pro-
tein insertion during stress or cell death conditions.  One potential 
mechanism, for this is by activating targeting inhibitory calmod-
ulin, which acts like a trap by binding toTA proteins under cer-
tain physiological conditions.  Although our experiments did not 
definitively demonstrate that Ca2+-activated calmodulin serves as 
the mechanism to trap TA proteins in the cytosol and prevent their 
insertion into the ER, we are hopeful that future experiments will 
elucidate the mechanism.  Our next step will be to determine if a 
shift in calcium disrupts TA protein insertion.  To do this, we can in-
crease intracellular calcium by treating cells with ionmycin, which 
binds to calcium, and monitoring TA protein insertion. This could 
also be done using forward chemical genetics, to screen for and 
determine a small molecule inhibitor of calmodulin.  Additional-
ly, we can measure cytosolic calcium concentration changes in the 
presence of Tg through calcium sensors like GCamp to determine 
whether the change in intracellular Ca2+ is significant.  Our other 
goal is to determine whether calmodulin is the factor that slows 
TA protein insertion after Tg treatment.  Since our results were in-
conclusive we plan to modify the TA protein-calmodulin chemi-
cal cross-linking experiment by optimizing the DSS cross linker 
or using other crosslinkers (DSS is a lysine-mediated cross linker, 
some proteins may not have a lysine properly positioned).  Another 
option to test our hypothesis that calmodulin under increased intra-
cellular calcium conditions acts like a TA protein trap, is to perform 
siRNA mediated knock down of calmodulin under Tg stress con-
ditions and observe the effects of TA protein insertion.  Finally, we 
wish to delve deeper into the characterization of TG’s effect on TA 
protein insertion.  To do this, we will perform more experiments an-
alyzing the concentration (minimum threshold), time, and substrate 
specificity of Tg’s effect on TA protein insertion.
Nonetheless, our results demonstrate that thagsigargin, an import-
ant and commonly used ER-stress inducer that has also attracted 
cancer research—mipsagargin, a prodrug of thapsigargin is current-
ly undergoing clinical trials for treatment of glioblastoma15—has a 
significant off-target effect, namely, reducing TA protein insertion 
into the ER.
EXPERIMENTAL PROCEDURES (MATERIALS AND METH-
ODS)
DNA constructs + Antibodies
To construct TA model substrates, PCR amplification of the gene 
in question was performed with Phusion High-Fidelity DNA poly-
merase (Thermo Fisher). A FLAG tag  (MDYKDDDDK) was add-
ed to the N-terminal primers.
Antibodies used for immunoblotting analysis are: Mouse α-HA-
HRP (Cell Signaling, # 400 2999S), Rat α-FLAG L5 (BioLegend, 
# 12775), Rabbit α-FLAG.
Cell culture:
HEK293- Flp-In™ T-REx™ 293 from Invitrogen and HEK293T 
cell lines were cultured with high glucose DMEM (Corning, Corn-
ing, NY), 10% FBS (Gibco, Gaithersburg, MD), 100 U/mL peni-
cillin, and 100 mg/mL streptomycin (Gibco) at 37o 442 C and 5% 
CO2. HEK 293-Flp-In T-Rex.
YURJ | Vol 2.1 Spring 20214
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Figure 5. HEK293 cells were transfected with FLAG-tagged βVamp2 and 
treated with Tg (1ug/mL) for 1 hour. Cells were treated with 0uM, 200 uM, 
and 500uM of DSS crosslinker before harvesting and immunoprecipitating 
for βVamp2 samples. 
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Transfection and Immunoprecipitation of TA proteins from cells
HEK293 cells (0.85 x 106 /well) were plated on polylysine-coat-
ed (0.1mg/mL) 6-well plates and transiently transfected with 2 
µg of the indicated TA plasmid constructs, and 5µL of Lipofect-
amine 2000 (invitrogen) mixed in Opti-MEM (Gibco). 24 hours 
after transfection, cells (non-control) were exposed to 0-1 hr of 
stress treatment with 1 ug/mL of Tg or 4 ug/mL DTT followed by 
incubation in cysteine- and methionine-free media with 10% dia-
lyzed FBS for 30 minutes, ER-stress added as well.  Cells were then 
labeled with 8.5 uL of 35S protein labelling mix for 30 mins.  Cells 
were rinsed with 1xPBS and chased with complete DMEM medi-
um.  The cells were harvested in RIPA buffer containing 50mM 
Tris-HCl pH 8.0, 150mM NaCl, 0.1% SDS, 1% Triton X-100, 0.5% 
Sodium Deoxycholate (Millipore Sigma), 1x complete protease in-
hibitor cocktail.  After centrifugation for 10 minutes at 20,000 g, the 
lysates were incubated with rat anti-FLAG beads for 1.5 hours with 
rotation.  The beads were then washed with 1 mL of RIPA buffer 
x3.  The washed beads were boiled with 50 uL of 2x SDS sample 
buffer for 5 minutes followed by SDS-PAGE and autoradiography. 
Cross linking between TA protein and cytosolic interacting part-
ner
HEK293 cells (0.85 x 106 /well) were plated on polylysine-coated 
(0.1mg/mL) 6-well plates and transiently transfected with 2 µg of 
the indicated βVamp2 plasmid, and 5µL of Lipofectamine 2000 (in-
vitrogen) mixed in Opti-MEM (Gibco) and induced with 100 ng/
mL of doxycycline. 24 hours after transfection, cells (non-control) 
were exposed to 30 minutes of stress treatment with 1 ug/mL of 
Tg followed by incubation in cysteine- and methionine-free media 
with 10% dialyzed FBS for 30 minutes.  Cells were then labeled 
with 8.5 uL of 35S protein labelling mix for 30 mins, ER-stress 
added as well.  Cells were rinsed with 2 mL of KHM buffer (20 mM 
Hepes pH 7.4, 110 mM KAc, 2mM MgAc) and incubated with 1 
mL of KHM buffer containing 0 uM, 200 uM, and 500 uM of DSS 
crosslinker (kept at room temperature) for 30 mins.  The crosslinker 
solution was discarded and reaction was quenched by addition 1 
mL of 0.1M Tris pH8 for 5 min on ice.  The cells were harvested 
in RIPA buffer with 1x complete  protease inhibitor cocktail.  After 
centrifugation for 10 minutes at 20,000 g, the lysates were incu-
bated with 12 uL of mouse anti-FLAG beads and incubated for 1.5 
hours with rotation.  The beads were then washed with 1 mL of 
RIPA buffer x3.  The washed beads were boiled with 50 uL of 2x 
SDS sample buffer for 5 minutes followed by immunoblotting with 
anti-FLAG antibodies for TA proteins.  The immunoprecipitants 
were analyzed by SDS-PAGE autoradiography.
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